1 EXHIBIT 4.4 CONFIDENTIAL TREATMENT - EDITED COPY OPTION AGREEMENTOption Agreement • March 29th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
RECITALSRights Agreement • July 28th, 2003 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 4.4Registration Rights Agreement • April 2nd, 1998 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
ARTICLE ICommon Stock Purchase Agreement • March 26th, 2003 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
ARTICLE 1 DEFINITIONSSupply Agreement • April 20th, 2000 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
RECITALSIndemnity Agreement • October 31st, 2003 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
ANDRights Agreement • October 14th, 1997 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
RECITALSAcquisition Agreement • April 30th, 1999 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
1 2 CONFIDENTIAL TREATMENT--EDITED COPYSciclone Pharmaceuticals Inc • May 15th, 2001 • Pharmaceutical preparations
2 3 (b) This Warrant may not be exercised as to fractional shares of Common Stock. In the event that the exercise of this Warrant, in full or in part, would result in the issuance of any fractional share of Common Stock, then in such event Warrant...Sciclone Pharmaceuticals Inc • July 23rd, 1998 • Pharmaceutical preparations • New York
SIGNATURE PAGE TO SECOND AMENDMENT OF EMPLOYMENT AGREEMENT]Employment Agreement • March 29th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
1 EXHIBIT 10.2 CONFIDENTIAL TREATMENT--EDITED COPY MATERIALS TRANSFER AGREEMENT This Agreement, made as of December 21, 2000, is by and between SciClone Pharmaceuticals, Inc. ("SciClone"), having a principal place of business at 901 Mariners Island...Confidential Treatment • May 15th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
1 EXHIBIT 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this "Rights Agreement"), entered into as of June 30, 1998, between Cheyenne LLC (the "Investor"), and SciClone Pharmaceuticals, Inc., a California corporation (the...Registration Rights Agreement • July 23rd, 1998 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
1 EXHIBIT 10.4 CONFIDENTIAL TREATMENT REQUESTED -- EDITED COPY REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT, dated as of October 26, 2000, by and between SciClone Pharmaceuticals, Inc., a California corporation (the "Company"), and UBS...Registration Rights Agreement • August 3rd, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
SCICLONE PHARMACEUTICALS, INC. 1,500,000 Shares of Common Stock, no par value PLACEMENT AGENCY AGREEMENTEscrow Agreement • November 12th, 1997 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 10.12 FIFTH AMENDMENT OF EMPLOYMENT AGREEMENT This Fifth Amendment of the Employment Agreement (this "Amendment") is entered into as of _______________, 2004 (the "Effective Date") by and between SciClone Pharmaceuticals, Inc. (the "Company")...Employment Agreement • March 15th, 2004 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
RECITALSSciclone Pharmaceuticals Inc • April 30th, 1999 • Pharmaceutical preparations • California
Serial Numbers of Licensed Patents: (1) U.S. Patent No. 5,366,977, issued November 22, 1994 (U.S. Patent Application Serial No. 07/952,965, filed September 29, 1992), entitled "Methods of Treating Cystic Fibrosis Using 8-Cyclopentyl-1,...Patent License Agreement • October 15th, 1996 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • District of Columbia
1 EXHIBIT 10.30 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, TOGETHER WITH THE REGULATIONS PROMULGATED THEREUNDER (THE "SECURITIES ACT"), AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR IN THE...Sciclone Pharmaceuticals Inc • November 17th, 1998 • Pharmaceutical preparations • California
EXHIBIT 10.4 AMENDMENT NO. 3Sciclone Pharmaceuticals Inc • August 6th, 2004 • Pharmaceutical preparations
ARTICLE 1 INTERPRETATIONManufacturing and Supply Agreement • March 15th, 2004 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
1 EXHIBIT 10.1 CONFIDENTIAL TREATMENT--EDITED COPY REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT, dated as of February 16, 2001, by and between SciClone Pharmaceuticals, Inc., a California corporation (the "Company"), and UBS AG, London...Registration Rights Agreement • May 15th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
LICENSE, DEVELOPMENT AND SUPPLY AGREEMENT BETWEENDevelopment and Supply Agreement • April 1st, 1997 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 6th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
SCICLONE PHARMACEUTICALS, INC. STOCK OPTION AGREEMENTStock Option Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
SciClone Pharmaceuticals, Inc. (the “Company”) has granted to the Participant named in the Notice of Grant of Stock Option (the “Grant Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain shares of Stock upon the terms and conditions set forth in the Grant Notice and this Option Agreement. The Option has been granted pursuant to and shall in all respects be subject to the terms and conditions of the SciClone Pharmaceuticals, Inc. 2015 Equity Incentive Plan (the “Plan”), as amended to the Date of Grant, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of, and represents that the Participant has read and is familiar with, the Grant Notice, this Option Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of shares issuable pursuant to the Option (t
EXHIBIT 99.1 SUBSCRIPTION AGREEMENT This Subscription Agreement (the "Agreement") is made and entered into as of January 14, 2000 by and among SciClone Pharmaceuticals, Inc., a California corporation (the "Company"), and those parties listed on the...Subscription Agreement • April 25th, 2000 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
1 EXHIBIT 10.3 CONFIDENTIAL TREATMENT--EDITED COPY MANUFACTURING SERVICES AGREEMENT BY AND BETWEEN SCICLONE PHARMACEUTICALS INTERNATIONAL LTD.Manufacturing Services Agreement • May 15th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
SCICLONE PHARMACEUTICALS, INC. RESTRICTED STOCK UNITS AGREEMENTRestricted Stock Units Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
SciClone Pharmaceuticals, Inc. has granted to the Participant named in the Notice of Grant of Restricted Stock Units (the “Grant Notice”) to which this Restricted Stock Units Agreement (the “Agreement”) is attached an Award consisting of Restricted Stock Units (each a “Unit”) subject to the terms and conditions set forth in the Grant Notice and this Agreement. The Award has been granted pursuant to and shall in all respects be subject to the terms conditions of the SciClone Pharmaceuticals, Inc. 2015 Equity Incentive Plan (the “Plan”), as amended to the Date of Grant, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of and represents that the Participant has read and is familiar with the Grant Notice, this Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of the shares issuable pursuant to the Award (the “Plan Prosp
INDEMNITY AGREEMENTIndemnity Agreement • August 9th, 2006 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Indemnity Agreement, dated as of June 2, 2006, is made by and between SciClone Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Dr. Friedhelm Blobel (the “Indemnitee”).
RECITALSControl Agreement • March 29th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
AMENDMENT NO. 1 TO STRUCTURED EQUITY LINE FLEXIBLE FINANCING(SM) AGREEMENTSciclone Pharmaceuticals Inc • June 23rd, 1999 • Pharmaceutical preparations • New York
AMENDMENT NO. 1 to PREFERRED STOCK INVESTMENT AGREEMENTPreferred Stock Investment Agreement • June 24th, 1999 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
RECITALSPurchase and Sale • December 2nd, 1997 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 10.11 EMPLOYMENT AGREEMENT This Employment Agreement (the "Agreement") is entered into as of February 1, 1996 between SciClone Pharmaceuticals, Inc. a California corporation, (the "Company"), and Donald R. Sellers, an individual ("Employee")....Employment Agreement • March 15th, 2004 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT A TO WARRANT SCICLONE PHARMACEUTICALS, INC. WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • April 25th, 2000 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
